- CAPR: Capricor Therapeutics Inc Latest Stock Price, Analysis, News and . . .
Get real-time Capricor Therapeutics Inc (CAPR) stock price, news, financials, community insights, and trading ideas Join 10 million+ investors and traders tracking markets in real-time on Stocktwits
- Capricor Therapeutics, Inc. (CAPR) - Yahoo Finance
Find the latest Capricor Therapeutics, Inc (CAPR) stock quote, history, news and other vital information to help you with your stock trading and investing
- CAPR Stock Price | Capricor Therapeutics Inc. Stock Quote (U. S. : Nasdaq . . .
CAPR | Complete Capricor Therapeutics Inc stock news by MarketWatch View real-time stock prices and stock quotes for a full financial overview
- Capricor Therapeutics Announces Positive Topline Results from Pivotal . . .
SAN DIEGO, Dec 03, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced positive topline results from its pivotal Phase 3 HOPE-3 trial evaluating Deramiocel, the Company’s investigational cell
- Capricor Therapeutics Inc (CAPR) Stock Price News - Google
Get the latest Capricor Therapeutics Inc (CAPR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions
- Capricor Therapeutics (CAPR) Stock Price Overview
A detailed overview of Capricor Therapeutics, Inc (CAPR) stock, including real-time price, chart, key statistics, news, and more
- CAPR News Today | Why did Capricor Therapeutics stock go up today?
Capricor Therapeutics, Inc (NASDAQ: CAPR) saw a dramatic run-up this week after a positive Phase III readout for its deramiocel cell therapy in Duchenne cardiomyopathy, but later pulled back amid a proposed share offering and profit-taking
- CAPR Stock Skyrockets 282% in a Week: Heres What You Need to Know
CAPR’s lead product candidate and only clinical pipeline asset, deramiocel, is an investigational, allogeneic cardiac-derived cell therapy
|